全文获取类型
收费全文 | 9528篇 |
免费 | 600篇 |
国内免费 | 76篇 |
专业分类
耳鼻咽喉 | 159篇 |
儿科学 | 243篇 |
妇产科学 | 282篇 |
基础医学 | 1068篇 |
口腔科学 | 141篇 |
临床医学 | 881篇 |
内科学 | 2481篇 |
皮肤病学 | 134篇 |
神经病学 | 996篇 |
特种医学 | 289篇 |
外科学 | 1621篇 |
综合类 | 90篇 |
一般理论 | 2篇 |
预防医学 | 618篇 |
眼科学 | 77篇 |
药学 | 524篇 |
1篇 | |
中国医学 | 30篇 |
肿瘤学 | 567篇 |
出版年
2024年 | 12篇 |
2023年 | 78篇 |
2022年 | 209篇 |
2021年 | 369篇 |
2020年 | 193篇 |
2019年 | 322篇 |
2018年 | 338篇 |
2017年 | 229篇 |
2016年 | 282篇 |
2015年 | 337篇 |
2014年 | 415篇 |
2013年 | 540篇 |
2012年 | 809篇 |
2011年 | 799篇 |
2010年 | 407篇 |
2009年 | 357篇 |
2008年 | 628篇 |
2007年 | 674篇 |
2006年 | 600篇 |
2005年 | 570篇 |
2004年 | 522篇 |
2003年 | 501篇 |
2002年 | 391篇 |
2001年 | 69篇 |
2000年 | 56篇 |
1999年 | 48篇 |
1998年 | 58篇 |
1997年 | 33篇 |
1996年 | 35篇 |
1995年 | 36篇 |
1994年 | 21篇 |
1993年 | 24篇 |
1992年 | 21篇 |
1991年 | 21篇 |
1990年 | 15篇 |
1989年 | 19篇 |
1988年 | 10篇 |
1987年 | 7篇 |
1985年 | 14篇 |
1984年 | 10篇 |
1983年 | 16篇 |
1982年 | 14篇 |
1981年 | 11篇 |
1980年 | 8篇 |
1977年 | 7篇 |
1976年 | 6篇 |
1974年 | 6篇 |
1973年 | 5篇 |
1971年 | 10篇 |
1970年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
Godofreda Vergeire-Dalmacion Nina T Castillo-Carandang Noel R Juban Maria Lourdes Amarillo Maria Pamela Tagle Emmanuel S Baja 《JMIR Public Health and Surveillance》2015,1(2)
Background
Paper-based adverse drug reaction (ADR) reporting has been in practice for more than 6 decades. Health professionals remain the primary source of reports, while the value of patients’ reporting is yet unclear. With the increasing popularity of using electronic gadgets in health, it is expected that the electronic transmission of reports will become the norm within a few years.Objective
The aims of this study are to investigate whether short messaging service or texting can provide an alternative or supplemental method for ADR reporting given the increasing role of mobile phones in health care monitoring; to determine the usefulness of texting in addition to paper-based reporting of ADRs by resident physicians; and to describe the barriers to ADR reporting and estimate the cost for setting up and maintaining a texting-computer reporting system.Methods
This was a pre-post cross-sectional study that measured the number of ADRs texted by 51 resident physicians for 12 months from the Department of Obstetrics and Gynecology and the Department of Adult Medicine of a tertiary government hospital in Manila, Philippines, with 1350-bed capacity. Reports were captured by a texting-computer reporting system. Prior to its implementation, key informant interview and focus group discussion were conducted. Baseline information and practice on the existing paper-based reporting system were culled from the records of the hospital’s Pharmacy and Therapeutics Committee. A postintervention survey questionnaire was administered at the end of 12 months.Results
Only 3 ADRs were texted by 51 resident physicians in 12 months (reporting rate 3/51 or 6%). By contrast, 240 ADRs from the paper-based reporting system from 848 resident physicians of the study hospital were collected and tabulated (reporting rate 240/848 or 28.3%). Texting ADRs was not efficient because of power interruption, competition with the existing paper-based reporting system, and unforeseen expiration of prepaid text loads/credits. The 3 ADRs texted were a report of vivid dreams and nightmares, a report of disturbing dreams and memory lapses, both of which were due to montelukast use, and a report of hepatitis from an isoniazid/rifampicin fixed-dose combination. Nineteen of 51 resident physicians (37%) registered in the reporting system responded to the postintervention survey. The most common reasons for not reporting ADRs were no adverse reaction identified 11/19 (58%) and restrictive reporting syntax 4/19 (21%). All doctors preferred a free form of reporting. The direct cost of the texting-based reporting system was calculated to be US $5581.40 and the indirect cost was US $9989.40. The total cost for texting-based ADR reporting system for 12 months was US $15,570.79.Conclusions
Reporting of ADRs via texting could be lower compared with an existing ADR paper-based system. Problems of Internet connectivity, reporting syntax, and expiration and reliability of text loads/credits should be addressed while implementing a text-based ADR reporting system in a developing country. 相似文献92.
93.
94.
Guajardo Emmanuel Giordano Thomas P. Westbrook Robert A. Black William C. Njue-Marendes Sarah Dang Bich N. 《AIDS and behavior》2022,26(6):1880-1891
AIDS and Behavior - We conducted a prospective cohort study of 450 patients new to an HIV clinic in Houston, TX, to examine the roles of life stressors and initial care experiences in predicting... 相似文献
95.
Purpose
Recent interest in complete mesocolic excision (CME) with central vascular ligation (CVL) or extended (D3) lymphadenectomy (EL) for curative resection of colon cancer has been driven by published series from experienced practitioners showing excellent survival outcomes and low recurrence rates. In this article, we attempt to clarify the role of CME or EL in modern colorectal surgery.Methods
A narrative review of the evidence for CME and EL in the curative treatment of colon cancer.Results
The principal of CME surgery, similar to total mesorectal excision (TME) for rectal cancer, is the removal of all lymphatic, vascular, and neural tissue in the drainage area of the tumour in a complete mesocolic envelope with intact mesentery, peritoneum and encasing fascia. Extended (D3) lymphadenectomy (EL) is based on similar principles. Sound anatomical and oncological arguments are made to support the principles of removing the tumor contained within an intact mesocolic facial envelope together with an extended lymph node harvest. Excellent oncological outcomes with minimal morbidity and mortality have been reported. This has led to calls for the standardisation of surgery for colon cancer using CME. However, there is conflicting evidence regarding the prognostic benefit of greater lymph node harvests and the evidence for an oncological benefit of CME is limited by methodology flaws and several potential confounding factors.Conclusions
Although there is a reasonable anatomical and oncological basis for these techniques, there are no randomised controlled trials from which to draw confident conclusions and there is insufficient consistent high quality evidence to recommend widespread adoption of CME.96.
SPONTANEOUS REMISSION IN ACUTE MYELOID LEUKAEMIA 总被引:1,自引:0,他引:1
Alain Delmer Emmanuel Heron Jean-Pierre Marie Robert Zittoun 《British journal of haematology》1994,87(4):880-882
97.
Almost 30 years after it was first described as a discrete clinical entity, the antiphospholipid syndrome (APS) remains a challenge for clinicians in a wide range of specialities. There remain ongoing issues regarding nomenclature, the expanding range of clinical manifestations, and management of certain APS patient subgroups. In addition to the presence of appropriate clinical features, the diagnosis of APS also fundamentally requires the finding of positive antiphospholipid antibody test result(s), and unfortunately much still has to be done to improve the robustness, reproducibility, and standardization of these assays. This article discusses ongoing dilemmas and issues related to clinical aspects of APS including (i) the derivation of the current nomenclature and the implications of recent proposals for its revision; (ii) the problems that the protean clinical manifestations pose for many clinicians, in particular those not intimately familiar with APS; (iii) the potential pitfalls of applying the APS classification criteria as diagnostic criteria (although no doubt tempting for nonspecialist clinicians); (iv) the concept of seronegative APS and the effect that recent proposed changes in antiphospholipid antibody testing strategies may have on this diagnosis; and finally (v) an overview of key developments in the clinical management of APS patients over the past 30 years. 相似文献
98.
Alexander Egbe Sorin V. Pislaru Mahmoud A. Ali Arooj R. Khan Amber N. Boler Hartzell V. Schaff Emmanuel Akintoye Heidi M. Connolly Vuyisile T. Nkomo Patricia A. Pellikka 《JACC: Cardiovascular Imaging》2018,11(7):951-958
Objectives
The purpose of this study was to review the institutional practice of surveillance transthoracic echocardiography (TTE) for diagnosing early prosthetic valve dysfunction (PVD).Background
Bioprosthetic valve thrombosis (BPVT) is an important cause of PVD, and guidelines do not recommend routine TTE during the first 5 years after valve implantation.Methods
The authors performed a retrospective case-control study of all suspected (imaging diagnosis) or confirmed (histopathological diagnosis) cases of BPVT from January 1997 through December 2016. Patients were matched 1:2 (age, sex, prosthesis position) to patients whose prostheses were explanted because of structural failure (SF). PVD was defined as a 50% increase above baseline gradient at valve implantation and classified as early (≤5 years) or late (>5 years) after implantation.Results
There were 94 BPVT (51 suspected, 43 confirmed) and 188 SF cases; patient age 61 ± 9 years; men 61 (65%). The prosthesis positions were aortic 56%; mitral 26%; tricuspid 15%; and pulmonary 3%. Early PVD was more common in the BPVT versus SF group: 83 of 94 (88%) versus 20 of 188 (11%) (p < 0.001). Time from implantation to PVD was shorter for BPVT than SF: 26 months (interquartile range [IQR]: 12 to 43 months) versus 74 months (IQR: 48 to 102 months) (p < 0.001). At the initial PVD diagnosis, 81% of BPVT and 90% of SF patients were asymptomatic. However, BPVT patients had rapid symptomatic deterioration, requiring intervention sooner after PVD diagnosis: 6 months (IQR: 4 to 7 months) versus 51 months (IQR: 22 to 55 months) (p < 0.001).Conclusions
Most patients with PVD due to BPVT were asymptomatic at initial diagnosis, which was made based on routine surveillance TTE, often performed before 5 years. BPVT, an acute disease process, requires timely diagnosis because patient conditions rapidly deteriorate. Further studies are needed to determine whether routine surveillance TTE should be considered for patients with bioprosthetic valves to identify pre-symptomatic features of BPVT in order to provide effective, appropriate therapy. 相似文献99.
100.
Immunohistochemical localization of interleukin-6 in peripheral human endocrine glands 总被引:2,自引:0,他引:2
Kontogeorgos G Messini I Kyrodimou E Giannikaki L Zois E Koukoulis G Tsagarakis S 《Endocrine》2002,17(2):135-140
Interleukin-6 (IL-6) is a pleiotropic cytokine with differentiation and growth-promoting effects. Extensive studies in experimental
animals denote that IL-6 is produced in various endocrine organs and participates in the local control of endocrine cell function.
The expression of this cytokine in human endocrine glands, however, has only been examined in a limited number of studies.
We investigated the immunohistochemical expression and localization of IL-6 in a variety of peripheral human endocrine glands.
In the adrenals, IL-6 immunoreactivity was detected in all three zones of the cortex. The reticularis and glomerulosa zones
were more heavily stained as compared with the slight immunoreactivity of the fasciculata zone. In the adrenal medulla, chromaffin
and sustentacular cells were variably positive. A substantial number of follicular thyroid cells were strongly immunoreactive
for IL-6 in all normal and hyperplastic thyroids examined. Parafollicular cells were negative. Parathyroid chief cells were
mildly positive; selective and more intense staining was observed in acidophilic cells. Pancreatic islet cells were variably
positive. In the testis positive staining was selectively observed in both Leydig and Sertoli cells. In conclusion, IL-6 immunoreactivity
is present in almost all the human endocrine glands and it expressed in a cell-specific manner. These observations provide
further support for the existence of local immune-endocrine interactions. 相似文献